Press release
Acute Kidney Injury Therapeutics Pipeline Analysis Report 2018
Access Report Summary with Detailed TOC@ https://www.psmarketresearch.com/market-analysis/acute-kidney-injury-therapeutic-pipeline-analysis
Various health organizations such as National Institute of Diabetes and Digestive and Kidney Diseases and Small Business Innovation Research (SBIR) program of the U.S. Small Business Administration (SBA) are strengthening the growth of AKI therapeutics pipeline. For instance, TheraSource LLC received a funding of $335,318 from SBIR for its research project aimed at demonstrating the feasibility of developing recombinant human milk fat globule epidermal growth factor rhMFG E, as a novel and effective therapeutic for treating patients suffering with AKI, associated with ischemia due to low renal perfusion.
Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/acute-kidney-injury-therapeutic-pipeline-analysis/report-sample
There has been an increase in the number of patents approved for the development of drug candidates for the treatment of AKI. For instance, in October 2016, the USPTO issued U.S. Patent 9,464,114 to Arch BioPartners, entitled, “Peptides that Block Leukocyte Recruitment and Methods of Use”. This was the first patent issued protecting the composition and method of use for Metablok.
Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=acute-kidney-injury-therapeutic-pipeline-analysis
Most of the companies are developing innovative technologies for the synthesis or production of drug candidates for the treatment of AKI. For instance, Quark Pharmaceuticals Inc. is using an innovative technology platform for generation of chemically modified siRNA compounds and their delivery to the desired organs. These are particularly well-suited to exploit the potential of siRNA for therapeutic applications. Also, Silver Creek Pharmaceuticals Inc. is using smart growth factor technology platform for the development of growth factors that play an important role in development, maintenance of tissue homeostasis, and pathology of many disease states.
Some of the key players involved in the development of AKI therapeutics include Alloksys Life Sciences B.V., Stealth BioTherapeutics Inc., and Angion Biomedica Corp.
About P&S Market Research
P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research-based consulting services across a range of industries.
With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.
Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acute Kidney Injury Therapeutics Pipeline Analysis Report 2018 here
News-ID: 1104821 • Views: …
More Releases for AKI
Acute Kidney Injury (AKI) Disease Treatment Market Size and Forecast US$31.600 b …
Acute kidney failure can be deadly and requires serious therapy. Nonetheless, intense kidney disappointment might be reversible. On the off chance that you're generally healthy, you might recuperate ordinary or almost typical kidney function.
The Global Acute Kidney Injury (AKI) Disease Treatment market was valued at US$29.612 billion in 2022 and is expected to grow at a CAGR of +1% over the forecast period to reach a market size of US$31.600…
Acute Kidney Injury (AKI) Equipment Market global outlook and forecast 2021 -202 …
The Global Acute Kidney Injury (AKI) Equipment Market research report is a careful examination of the worldwide industry which has been a region of enthusiasm for a Acute Kidney Injury (AKI) Equipment makers, organizations, authorities, chiefs, and likely speculators, and analysts. The report profoundly lights up noteworthy features in the business, including a contention situation, condition, portions, showcase size, share, gainfulness, development potential, and…
Increasing Prevalence of Acute Kidney Injury (AKI) and Chronic Kidney Disease to …
The growing prevalence of kidney disorders is expected to be the major factor driving the growth of the drug-induced nephrotoxicity treatment market over the forecast period. Increasing geriatric who are more prone drugs toxicity is also one of the key factor which is driving the drug-induced nephrotoxicity treatment. For instance, more than 661,000 American have kidney failure and in 2013 more than 47,000 American died from kidney disease (source: National…
Acute Kidney Injury (AKI) Market Pipeline Insight- (2025) High Growth Opportunit …
Acute Kidney Injury (AKI) Pipeline Insight, 2020" Report gives comprehensive overview Of Present Clinical Development Scenario And Growth Prospects Across The Acute Kidney Injury (AKI) Market. A Detailed Picture Of The Acute Kidney Injury (AKI) Pipeline Landscape Is Provided, Which Includes The Disease Overview And Acute Kidney Injury (AKI) Treatment Guidelines. A Better Understanding of Disease Pathogenesis Contributing To The Development Of Novel Therapeutics For Acute Kidney Injury (AKI).
Get…
Acute Kidney Injury (AKI) Therapeutics to Witness Significant Growth due to Posi …
AKI or acute kidney failure is a common medical condition reported among hospitalized patients, especially those with multiple comorbid conditions. AKI can occur due to various reasons including decreased renal perfusion, and obstruction of the urinary collecting system. Dehydration, abdominal pain, rise in blood pressure, mild back pain, and vomiting are some of the symptoms associated with the disease.
Download free sample copy of report at: https://www.pharmaproff.com/request-sample/1253
AKI is diagnosed through various…
Home Retailing in Portugal Market Show at 2.3% CAGR to 2022 | IKEA, Leroy Merlin …
Home Retailing in Portugal Market Shares Summary and Forecasts to 2022
"Home Retailing in Portugal, Market Shares, Summary and Forecasts to 2022", provides data for historic and forecast retail sales, and also includes information on the business environment and country risk related to Portugal retail environment. In addition, it analyzes the key consumer trends influencing Portugal home industry.
In 2017, home sector sales in Portugal stood at 4.6 billion and are projected…
